Table 2. Strength of evidence for individual biomarkers for diagnosis and prognosis of HF.
| Biomarker | Diagnostic Capability | Prognostic Capability |
|---|---|---|
| BNP | +++ | +++ |
| NT-proBNP | +++ | +++ |
| ST2 | - | ++ |
| GDF-15 | - | + |
| Galectin | - | + |
| MR-proANP | ++ | ++ |
| NGAL | +++ | +++ |
| Hs-Tn | +++ | +++ |
| MR-proADM | - | +++ |
| Procalcitonin | +++ | +++ |
+: indicates strength; -: indicates lack of data suggesting strength; NT-proBNP: Amino terminal pro B-type natriuretic peptide; GDF-15: growth-differentiation factor-15; Hs-Tn: high sensitivity troponins; MR-proANP: Mid-regional atrial natriuretic peptide; MR-proADM: Mid-regional pro adrenomedullin